ASX:BIOHousehold & Personal ProductsPersonal Care Products
Biome Australia Ltd
$0.325
$0.020 (5.80%)
Day Range
$0.320 – $0.350
52 Week Range
$0.200 – $0.540
Volume
105.06K
Avg Volume (10D)
332.69K
Market Cap
$74.10M
P/E Ratio
346.94
Price Chart
OHLC · volume · moving averages
$0.325-$0.085 (-20.73%)over 6M
Hi$0.430Lo$0.200Avg Vol265.1K
Price-sensitive newsVolumePrev close · 52W rangeDrag the handles below to zoom
Market Statistics
Today's trading range
Open
$0.350
Previous Close
$0.345
Day High
$0.350
Day Low
$0.320
52 Week High
$0.540
52 Week Low
$0.200
Valuation
Fundamental multiples
Market Cap
74.10M
Shares Outstanding
228.00M
P/E Ratio (Annual)
346.94
P/E Ratio (TTM)
80.95
Price to Book
12.49
Trading Activity
Volume & order book
Volume
105.06K
Value Traded
34.77K
Bid
$0.325 × 42,152
Ask
$0.330 × 10,000
Performance
Returns across timeframes
1 Day
3.03%
5 Day
25.93%
13 Week
46.24%
52 Week
-37.04%
YTD
-19.05%
Technical Indicators
Momentum & moving averages
RSI (14)
59.43
50-Day SMA
$0.278
200-Day SMA
$0.342
— From the desk
Latest News
Biotechnology
Biome Australia Enters Probiotics Market in China with Exclusive H&S Global Deal
Biome Australia secures exclusive China CBEC deal with H&S Global for Activated Probiotics; aims for FY27 launch in US$10.8B market.
Biotechnology
Biome Australia Reports Record $23.9m Sales Revenue for FY26
Biome Australia posts record FY26 revenue of $23.9m, up 30%, led by Activated Probiotics; onshore manufacturing deal boosts 2027 outlook.
Biotechnology
Biome Australia to Commence Domestic Production of Activated Probiotics Range
Biome Australia moves to onshore production of Activated Probiotics, targeting margin rise from 61% toward 65%+ as inventory and lead times shrink.
Biotechnology
Biome Australia Extends Exclusive Probiotical Supply Agreement Through 2028
Biome Australia extends exclusive Probiotical supply to 2028, securing supply amid expansion; H1 FY2026 revenue $12.4m, EBITDA-positive.